Bimekizumab in Refractory Pityriasis Rubra Pilaris
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris.
Potestio L, DAgostino M, Portarapillo A, Esposito V, Tommasino N, Salsano A Life (Basel). 2024; 14(8).
PMID: 39202665 PMC: 11355122. DOI: 10.3390/life14080923.